Company intelligence / Profile preview
Altheia Science
Milan, Lombardia, Italyaltheiascience.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Altheia Science has active collaborations and robust manufacturing partnerships—in particular with Anemocyte for plasmid DNA and viral vector supply—accelerating development of cell and gene therapies for autoimmune diseases; no published clinical results yet but the company is described as pioneering and advancing toward clinical trials.
- Therapeutic areas
- ImmunologyOncology
- Modalities
- Cell therapyGene therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Anemocyte (manufacturing, plasmid DNA, cell banks, viral vector supply)
Beyond the preview
Go deeper on Altheia Science.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Altheia Science.